Multislice Spiral Computed Tomography Imaging in Evaluating Hemophilic Arthropathy

Hemophilic arthropathy (HA) is a debilitating complication of hemophilia characterized by repeated intra-articular hemorrhages leading to synovitis, cartilage degradation, and bone destruction. Imaging plays a pivotal role in evaluating HA progression, with magnetic resonance imaging (MRI) traditionally regarded as the gold standard. However, limitations such as high cost, long scan times, contraindications in patients with metal implants, and challenges in positioning limbs with severe deformities hinder its widespread use. This study explores the utility of multislice spiral computed tomography (MSCT) as an alternative imaging modality for assessing HA, comparing its performance against MRI and X-ray while aligning with the International Prophylaxis Study Group (IPSG) scoring system.

Study Design and Methodology

A prospective analysis was conducted on 73 joints (42 knees, 19 ankles, 5 elbows, 7 hips) from 38 male hemophilia A patients aged 7–46 years. All joints underwent X-ray, MSCT, and MRI within a 48-hour window. The X-ray Pettersson score classified joints into mild (0 points), moderate (1 mm joint space, 2: ≤1 mm joint space).

MSCT scans were performed on a 64-slice CT scanner (GE Discovery CT 750 HD) with low-dose protocols (80–100 kV, automatic mA modulation, 0.625 mm slice thickness) and adaptive statistical iterative reconstruction for noise reduction. MRI utilized a 3.0 T Siemens MAGNETOM Prisma with joint-specific coils and sequences (T1-weighted imaging and proton density-weighted fat-suppressed imaging) in axial, sagittal, and coronal planes. Two blinded radiologists analyzed images, resolving discrepancies through consensus. Statistical analyses included Wilcoxon signed-rank tests for score comparisons, Spearman correlation for score associations, and Kappa tests for intermodality agreement.

Key Findings

Effusion/Hemarthrosis

MRI outperformed CT in detecting small effusions (≤1.5 mm thickness), identifying 52% (25/48) of cases versus CT’s 0% (Z = −4.796, P 1.5 mm), CT and MRI showed perfect agreement (20 joints scored identically). Hemorrhagic effusions on CT were defined by attenuation >45 Hounsfield units (HU), correlating with MRI’s hyperintense signals on PD-FS sequences.

Synovial Hypertrophy and Hemosiderin Deposition

In mild disease, MRI detected synovial hypertrophy and hemosiderin deposits more sensitively, scoring 1–2 points in 63% (5/8 synovial) and 47% (7/15 hemosiderin) of joints, whereas CT scored these as 0. For moderate-to-severe groups, CT and MRI demonstrated strong agreement (Kappa > 0.81). Synovial thickening on CT appeared as soft tissue densities (>50 HU), while hemosiderin manifested as patchy hyperdensities. MRI’s superiority in mild cases stemmed from its ability to differentiate subtle synovial enhancements and hemosiderin’s low-T2 signal.

Bone Erosion and Cysts

CT excelled in detecting submillimeter bone erosions and cysts (minimum size: 0.8 mm vs. MRI’s 1.3 mm). CT identified 22 erosions and 19 cysts missed by MRI, particularly in osteoporotic regions where MRI’s resolution limited visualization. Conversely, MRI missed three cystic lesions due to partial volume effects. Overall, CT and MRI scores for bone changes showed near-perfect agreement (Kappa > 0.84).

Cartilage Assessment and Joint Space Narrowing

CT’s joint space narrowing scores strongly correlated with MRI’s cartilage injury grades (r = 0.905, P 1 mm (CT score 1) corresponded to MRI’s partial-thickness cartilage loss (score 2–3), while spaces ≤1 mm (CT score 2) matched full-thickness cartilage loss (MRI score 4). Although CT cannot visualize cartilage directly, its surrogate measure via joint space provided a reliable proxy for advanced cartilage damage.

Total Score Correlation

Total CT and MRI scores exhibited strong correlation (r = 0.975, P < 0.05), with higher concordance in moderate (r = 0.974) and severe (r = 0.971) groups than in mild disease (r = 0.773). This suggests CT’s efficacy in staging advanced HA but limitations in early synovitis detection.

Clinical Implications and Limitations

MSCT offers rapid, accessible, and cost-effective evaluation of HA, particularly for patients ineligible for MRI. Its high-resolution bone imaging, moderate soft tissue contrast, and low radiation dose (optimized via modern protocols) make it suitable for routine monitoring. However, MRI remains superior for early synovitis, mild hemosiderin deposits, and cartilage-specific grading.

Study limitations include a modest sample size dominated by knee joints, potential selection bias (patients undergoing all three imaging modalities), and the exclusion of ligamentous/meniscal assessments. Future studies should expand to multicenter cohorts and incorporate advanced CT techniques like dual-energy imaging for improved soft tissue characterization.

Conclusion

This study validates MSCT as a viable alternative to MRI for evaluating hemophilic arthropathy, particularly in moderate-to-severe cases. While MRI retains superiority in detecting early synovial inflammation and cartilage changes, CT’s strengths in bone erosion visualization, rapid acquisition, and lower cost position it as a pragmatic tool for resource-limited settings and longitudinal monitoring. Integrating CT into existing HA management protocols could enhance patient access to timely imaging, ultimately improving clinical outcomes.

doi.org/10.1097/CM9.0000000000000876

Was this helpful?

YesNo

0 / 0